ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

<link med fakultaet med-detailseiten news-detail article rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv>

Most Recent Papers

Scalable Generation of Multiphoton Entangled States by Active Feed-Forward and Multiplexing, Phys. Rev. Lett. 129, 150501arXiv:1908.05722.

Detection of Few Hydrogen Peroxide Molecules Using Self-Reporting Fluorescent Nanodiamond Quantum SensorsJACS 144, 12642.

Robust macroscopic matter-wave interferometry with solidsPhys. Rev. A 105, 063313arXiv:2107.14794.

Fingerprint and Universal Markovian Closure of Structured Bosonic EnvironmentsPhys. Rev. Lett. 129, 140603.



Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89069 Ulm

Tel: ++49 / 731 / 50 - 22911
Fax: ++49 / 731 / 50 - 22924

Office: Building M26, room 4117

Click here if you are interested in applying to the group